Serum phosphate within the normal range is a strong predictor of CKD progression. Patients who had renal events had significantly higher serum phosphate levels than those who did not (4.2 vs. 3.7 ...

High serum phosphorus levels in patients with normal renal function are associated with a greater risk of end-stage renal disease (ESRD) and death, according to researchers. In a retrospective study ...

A group of FDA advisors recommended approval of tenapanor (Ibsrela) for the control of serum phosphorus levels in adults with chronic kidney disease (CKD) on dialysis, both as a single agent and in ...

Sevelamer carbonate 800 mg; tabs. Patients with CKD can develop hyperphosphatemia as a result of retained phosphorus, which may lead to ectopic calcification. Hyperphosphatemia plays a role in the ...

The non–calcium phosphate binder lanthanum carbonate (Fosrenol) had absolutely no effect on any intermediate marker of cardiovascular (CV) risk or bone and mineral metabolism in patients with ...

Hyperphosphatemia is a condition that means you have high levels of phosphorus in your body. It can happen due to your diet or a change in your kidneys’ function. Often, hyperphosphatemia has no ...

Please provide your email address to receive an email when new articles are posted on . You've successfully added to your alerts. You will receive an email when new content is published. Click Here to ...

LOS ALTOS, Calif., July 18, 2023 (GLOBE NEWSWIRE) -- Unicycive Therapeutics, Inc. (Nasdaq: UNCY), a clinical-stage biotechnology company developing therapies for patients with kidney disease (the ...